Gencove Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$10M
- Investors
-
13
Gencove General Information
Description
Developer of a sequencing platform designed to make whole-genome sequencing fast, affordable and actionable. The company develops molecular and computational tools to enable high-throughput and low-cost genome sequencing technology for industries from agriculture to pharma, enabling researchers to have access to genomic data.
Contact Information
Website
www.gencove.comCorporate Office
- 430 East 29th Street
- New York, NY 10016
- United States
Corporate Office
- 430 East 29th Street
- New York, NY 10016
- United States
Gencove Timeline
Gencove Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Later Stage VC (Series A) | 26-Oct-2021 | $10M | Completed | Generating Revenue | ||
5. Seed Round | 19-Apr-2021 | Completed | Generating Revenue | |||
4. Grant | 31-Oct-2019 | Completed | Generating Revenue | |||
3. Seed Round | 11-Feb-2019 | Completed | Generating Revenue | |||
2. Seed Round | 05-Jun-2017 | $1M | $1M | Completed | Startup | |
1. Accelerator/Incubator | 01-Jan-2016 | Completed | Startup |
Gencove Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | ||||||||
Seed 3 | ||||||||
Seed 2 | 4,469,273 | $0.000010 | $0.72 | $0.72 | 1x | $0.72 | 16.02% | |
Seed | 2,461,840 | $0.000010 | $0.41 | $0.41 | 1x | $0.41 | 8.82% |
Gencove Comparisons
Industry
Financing
Details
Gencove Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Centrillion Technologies | Venture Capital-Backed | Palo Alto, CA | ||||
Complete Genomics | Formerly VC-backed | San Jose, CA | ||||
Fabric Genomics | Venture Capital-Backed | Oakland, CA |
Gencove Patents
Gencove Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190284625-A1 | Methods for joint low-pass and targeted sequencing | Inactive | 16-Mar-2018 |
Gencove Signals
Gencove Investors (13)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
HBM Genomics | Venture Capital | Minority | ||
Lewis & Clark AgriFood | Growth/Expansion | Minority | ||
Techammer | Angel (individual) | Minority | ||
Small Business Innovation Research and Small Business Technology Transfer Programs | Government | Minority | ||
Alexandria Venture Investments | Venture Capital | Minority |
Gencove FAQs
-
When was Gencove founded?
Gencove was founded in 2015.
-
Where is Gencove headquartered?
Gencove is headquartered in New York, NY.
-
What is the size of Gencove?
Gencove has 29 total employees.
-
What industry is Gencove in?
Gencove’s primary industry is Media and Information Services (B2B).
-
Is Gencove a private or public company?
Gencove is a Private company.
-
What is the current valuation of Gencove?
The current valuation of Gencove is
. -
What is Gencove’s current revenue?
The current revenue for Gencove is
. -
How much funding has Gencove raised over time?
Gencove has raised $16M.
-
Who are Gencove’s investors?
HBM Genomics, Lewis & Clark AgriFood, Techammer, Small Business Innovation Research and Small Business Technology Transfer Programs, and Alexandria Venture Investments are 5 of 13 investors who have invested in Gencove.
-
Who are Gencove’s competitors?
Centrillion Technologies, Complete Genomics, and Fabric Genomics are competitors of Gencove.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »